Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ther Apher Dial ; 16(6): 600-4, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23190522

ABSTRACT

Serum receptor activator of nuclear factor-κ B ligand and osteoprotegrin are mediated to vascular calcification in the general population. Our knowledge is very sparse in hemodialysis and renal transplant patients. Receptor activator of nuclear factor-κ B ligand, osteoprotegrin, intact parathyroid hormone, calcium, and phosphorus were measured in blood samples of 45 hemodialysis and 45 age-matched renal transplant patients. Osteoprotegrin (P = 0.001) and intact parathyroid hormone (P = 0.001) levels in the hemodialysis patients were higher than the renal transplant recipients. Osteoprotegrin had positive correlation with duration of dialysis and age in the hemodialysis (r = 0.88, P = 0.001 and r = 0.34, P = 0.02, respectively) and renal transplant patients (r = 0.92, P = 0.001 and r = 0.46, P = 0.001, respectively). Hemodialysis patients have higher osteoprotegrin levels than the renal transplant recipients. It may act as a protective factor for renal osteodystrophy or only as a secondary phenomenon of advanced renal failure.


Subject(s)
Kidney Transplantation , Osteoprotegerin/blood , Parathyroid Hormone/blood , RANK Ligand/blood , Renal Dialysis , Adult , Age Factors , Calcinosis/pathology , Calcium/blood , Female , Humans , Male , Middle Aged , Phosphorus/blood , Renal Insufficiency/surgery , Renal Insufficiency/therapy , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...